1. Home
  2. BWAY vs BWFG Comparison

BWAY vs BWFG Comparison

Compare BWAY & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • BWFG
  • Stock Information
  • Founded
  • BWAY 2003
  • BWFG 2002
  • Country
  • BWAY Israel
  • BWFG United States
  • Employees
  • BWAY N/A
  • BWFG N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • BWFG Major Banks
  • Sector
  • BWAY Health Care
  • BWFG Finance
  • Exchange
  • BWAY Nasdaq
  • BWFG Nasdaq
  • Market Cap
  • BWAY 280.7M
  • BWFG 333.1M
  • IPO Year
  • BWAY 2019
  • BWFG N/A
  • Fundamental
  • Price
  • BWAY $16.00
  • BWFG $42.80
  • Analyst Decision
  • BWAY Strong Buy
  • BWFG Buy
  • Analyst Count
  • BWAY 2
  • BWFG 2
  • Target Price
  • BWAY $18.00
  • BWFG $42.00
  • AVG Volume (30 Days)
  • BWAY 50.6K
  • BWFG 36.7K
  • Earning Date
  • BWAY 11-11-2025
  • BWFG 10-23-2025
  • Dividend Yield
  • BWAY N/A
  • BWFG 1.86%
  • EPS Growth
  • BWAY 679.98
  • BWFG N/A
  • EPS
  • BWAY 0.11
  • BWFG 2.64
  • Revenue
  • BWAY $46,084,000.00
  • BWFG $81,749,000.00
  • Revenue This Year
  • BWAY $335.63
  • BWFG $66.56
  • Revenue Next Year
  • BWAY $22.10
  • BWFG $14.45
  • P/E Ratio
  • BWAY $54.26
  • BWFG $16.25
  • Revenue Growth
  • BWAY 26.50
  • BWFG 0.32
  • 52 Week Low
  • BWAY $7.84
  • BWFG $26.39
  • 52 Week High
  • BWAY $17.00
  • BWFG $46.85
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 59.17
  • BWFG 46.30
  • Support Level
  • BWAY $14.55
  • BWFG $41.39
  • Resistance Level
  • BWAY $15.70
  • BWFG $43.58
  • Average True Range (ATR)
  • BWAY 0.69
  • BWFG 1.03
  • MACD
  • BWAY -0.01
  • BWFG -0.33
  • Stochastic Oscillator
  • BWAY 80.77
  • BWFG 29.23

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

Share on Social Networks: